QuidelOrtho Grants Equity Awards to New Employees
QuidelOrtho Corporation announced it has granted equity awards totaling 50,323 shares of common stock to two newly hired, non-executive employees. The grants were made under the company's 2026 Inducement Plan.
QuidelOrtho Corporation, a provider of diagnostic solutions, announced on October 15, 2026, that its Compensation Committee approved the grant of equity awards to two new, non-executive employees. These awards are referred to as Inducement Grants.
The grants were issued under the company's 2026 Inducement Plan, which is specifically designed to grant equity awards to individuals newly joining the company, or returning after a period of non-employment, as an inducement to enter into employment. This practice complies with Nasdaq Listing Rule 5635(c)(4).
The Inducement Grants consist of Restricted Stock Units (RSUs) for an aggregate of 50,323 shares of QuidelOrtho's common stock. The RSUs were granted on October 15, 2026, and will vest in equal annual installments over the first three years of employment, contingent on continued service.
QuidelOrtho focuses on advancing diagnostic solutions across areas such as clinical chemistry, immunoassay, immunohematology, and molecular testing to improve patient outcomes.